Diode Bio Information

Diode Bio co-develops and co-invests in our Pharma partner's funding-constrained Phase I–II clinical candidates — swiftly advancing medicines that would otherwise be deprioritised, delayed, or forgotten to waiting patients. We partner with great Pharma R&D and BD teams to provide additional optionality and future value. Our team was built around a rare combination of talents in clinical science, operational execution, and partnering leadership. Diode Bio was founded by physician-scientists and industry leaders with complementary APAC deal-making, venture, clinical development, and business development track records. We are cross-functional team spanning clinical operations, regulatory affairs, compliance, and finance — each with deep APAC and global pharma backgrounds. Additionally we are supported by Global pharmaceutical executives, venture investors, R&D leaders, and CRO operators, world-class academic physicians and translational scientists and Partners that have deep and decades of expertise with our model. Diode Bio integrates AI across every stage of asset development — from opportunity discovery to clinical execution — amplified by decades of experience in pharmaceutical R&D and clinical operations across Asia Pacific. We are backed by strategic investors and regional leaders.